CIK: 1280154 - Address: C/o Urovant Sciences, Inc., 5281 California Avenue, Suite 100, Irvine, CA 92617
4 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret2131-110150332316158
P%wins33010010010010072

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/11/17 20:30
5/10/17
NVUSNovus Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsOcampo ChristineCAOSee RemaP1009.990108622D-94-92-34-32-27-503-3
3/7/12 09:02
3/6/12
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOcampo ChristineCAOVP,FinanP82.6043473I31-23-111-6-11-8-57
2/25/09 15:24
2/24/09
AVNRAvanir PharmaceuticalsCAHealthDrugPharmaceutical PreparationsOcampo ChristineCAOVP,FinanP50.43830122169S-2-110150332316
5/19/05 17:29
5/19/05
CGCPCardiogenesis Corp /caCAHealthOrthopOrthopedic, Prosthetic & SurgOcampo ChristineCAOVP,CFOP90.4350020New20D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact